IPO registrations (S-1, F-1) · Registrants

Lomond Therapeutics Holdings, Inc.

SEC CIK
1900520 · filings on EDGAR ↗
Former names
Venetian-1 Acquisition Corp. (2021–2024)
Registration
Form S-1, first filed 2024-11-27, last 2025-08-01; 1 initial registration, 4 amendments
Outcome
Withdrawal requested 2026-07-10
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
C/O LOMOND THERAPEUTICS HOLDINGS, INC., 8 THE GREEN STE 8490, Dover, DE 19901
EIN
87-2959575
EDGAR entity type
operating
Insiders and CEO pay
Lomond Therapeutics Holdings, Inc. on the corporate pages

Offering terms

Shares offered
32,673,624
Lead underwriters
of Contents

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2024-11-27S-1S-1 (registration)Lomond Therapeutics Holdings, Inc.0001213900-24-103445 ↗
2025-01-31S-1/AS-1/A (amendment)Lomond Therapeutics Holdings, Inc.0001213900-25-008902 ↗
2025-03-10S-1/AS-1/A (amendment)Lomond Therapeutics Holdings, Inc.0001213900-25-022311 ↗
2025-06-18S-1/AS-1/A (amendment)Lomond Therapeutics Holdings, Inc.0001213900-25-055292 ↗
2025-08-01S-1/AS-1/A (amendment)Lomond Therapeutics Holdings, Inc.0001213900-25-070684 ↗
2026-07-10RWRW (withdrawal request)Lomond Therapeutics Holdings, Inc.0001213900-26-076903 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2025-08-01S-1/Aregistration statement$3.2032,673,624$104,555,5961primary document; price sentence, shares headline, proceeds computed, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Jacobs Ian SethDirector,Officer,TenPercentOwner; OtherPresident, CEO, CFO, Secretary22022–2024
Tompkins Mark N.Director,TenPercentOwner; Other22022–2024
Dukes Iain D.Director,OfficerCEO and Chairman22024
Eilean Therapeutics, LLCTenPercentOwner12024
GORDON CARL LDirector22024
ORBIMED ADVISORS LLCDirector22024
OrbiMed Capital GP IX LLCDirector22024
OrbiMed Capital GP VIII LLCDirector22024
OrbiMed Capital GP VII LLCDirector22024
Rodriguez EddieDirector12024
Savchuk NikolayDirector,OfficerPresident and COO22024

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2024-11-18Lomond Therapeutics Holdings, Inc.Pharmaceuticals$63,915,492$53,915,492282

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerLomond Therapeutics Holdings, Inc.DEForm D private offeringsCIK (EXACT)
SEC filerLomond Therapeutics Holdings, Inc.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, DE first:

More with this interest.

In other datasets, the same topic (Health) in DE:

Interests: Pharmaceutical Preparations · Health